Shoe Pain Relief Spray
NDC Package 87288-001-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Shoe Pain Relief (lidocaine hci 4%) sprays is a medication used to prevent and relieve pain during certain medical procedures (such as inserting a tube into the urinary tract). This formulation utilizes a spray delivery system. Marketed by Sole Amie, this product is identified by NDC 87288-001 and is authorized under FDA application M017.

Identification & Billing

NDC Package Code
87288-001-01
Package Description
28 g in 1 CAN
Product Code
87288-001
11-Digit Billing Format
87288000101
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Shoe Pain Relief
Non-Proprietary Name
Lidocaine Hci 4%
Substance Name
Lidocaine Hcl
Dosage Form
Spray - A liquid minutely divided as by a jet of air or steam.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
LIDOCAINE HCL 4 g/100g
Pharmacologic Class
Usage Information
This medication is used to prevent and relieve pain during certain medical procedures (such as inserting a tube into the urinary tract). It is also used to numb the lining of the mouth, throat, or nose before certain medical procedures (such as intubation). Lidocaine jelly is also used to relieve pain caused by swelling of the urinary tract (urethritis). It works by numbing certain areas of the body that are moist. Lidocaine belongs to a class of drugs known as local anesthetics.

Regulatory & Marketing

Labeler Name
Sole Amie
Product Type
Human Otc Drug
FDA Application #
M017
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
12-01-2025
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 87288-001-01 identifies a specific commercial package of 28 g in 1 can of Shoe Pain Relief, a human over the counter drug labeled by Sole Amie. This spray is formulated for topical use and contains lidocaine hcl as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sole Amie on December 01, 2025. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

This medication is used to prevent and relieve pain during certain medical procedures (such as inserting a tube into the urinary tract). It is also used to numb the lining of the mouth, throat, or nose before certain medical procedures (such as intubation). Lidocaine jelly is also used to relieve pain caused by swelling of the urinary tract (urethritis). It works by numbing certain areas of the body that are moist. Lidocaine belongs to a class of drugs known as local anesthetics.

How is this Sole Amie product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 87288000101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
87288-001-01
11-Digit CMS (5-4-2)
87288-0001-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.